Monoclonal antibodies (mAbs) have been used as experimental treatments of multiple sclerosis (MS) since the 1980s, with the advantage of a high specificity for their target but disadvantages due to their immunogenicity
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives.
D'Amico E;PATTI, Francesco
2015-01-01
Abstract
Monoclonal antibodies (mAbs) have been used as experimental treatments of multiple sclerosis (MS) since the 1980s, with the advantage of a high specificity for their target but disadvantages due to their immunogenicityFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
monoclonal antibody therapy...pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
626.79 kB
Formato
Adobe PDF
|
626.79 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
